Biolyn Pharmaceutical B.V.
CJC-1295 with DAC pharmaceutical vial
In Stock
CAS: 863288-34-0

CJC-1295 with DAC

Long-Acting GHRH Analog with Drug Affinity Complex

CJC-1295 with DAC is a modified GHRH analog conjugated to a Drug Affinity Complex for extended half-life. Biolyn supplies research-grade CJC-1295 DAC for endocrine research and B2B partners.

Technical Profile

Modified GRF(1-29) with amino acid substitutions (Ala2, Gln8, Ala15, Leu27) conjugated to a reactive Drug Affinity Complex (DAC) that binds serum albumin in vivo, extending half-life to ~8 days.

CAS Number863288-34-0
Molecular Weight3,647.28 g/mol
Molecular FormulaC165H269N47O46
Purity>99% (HPLC)
FormLyophilized Powder
Storage-20C, desiccated, protected from light
Applications
Extended GH release researchGHRH receptor studiesEndocrine pharmacokineticsLong-acting peptide developmentB2B API supply
Sermorelin AcetateCJC-1295 without DAC
Biolyn Pharmaceutical B.V.
Age Verification & Research Use

Please confirm before you continue

Biolyn Pharmaceutical B.V. supplies products strictly to businesses and institutions for laboratory and research use. Our products are not for human or veterinary consumption.

  • I am at least 18 years of age.
  • I represent a business, research institution, or licensed manufacturer.
  • I understand all products are supplied for laboratory and research purposes only — not for human or veterinary consumption.

By entering you accept our research-use terms. B2B only. No retail / No B2C.